This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Zhongcheng Investment Management (Shanghai) Co., Ltd. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Wenhui Xia: Innovator in Chemosynthetic Peptides
Introduction
Wenhui Xia is a notable inventor based in Haikou, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative peptides. His work focuses on creating solutions that can inhibit toxins, showcasing his commitment to advancing pharmaceutical applications.
Latest Patents
Wenhui Xia holds a patent for a "Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxins and use thereof." This invention relates to a chemosynthetic cyclo-hepta modified peptide that can specifically inhibit the production of toxins through the binding of the RNAIII activator protein via autocrine mechanisms. The general formula of this chemosynthetic peptide is CH—(CH)m-X-G-(CQHWWHWYC)—(R)n-Y. The results indicate that the modified peptide is well-dissolved in water and exhibits good activity against toxins.
Career Highlights
Wenhui Xia is associated with Zhongcheng Investment Management (Shanghai) Co., Ltd. His work in this company has allowed him to explore and develop innovative solutions in the pharmaceutical field. His dedication to research and development has positioned him as a key figure in his area of expertise.
Collaborations
Wenhui Xia has collaborated with notable colleagues, including Ningsheng Shao and Guang Yang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Wenhui Xia's contributions to the field of chemosynthetic peptides highlight his innovative spirit and dedication to improving pharmaceutical applications. His work continues to inspire advancements in biochemistry and toxin inhibition.